<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Chromium(III) picolinate</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Chromium(III)_picolinate">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Chromium(III) picolinate</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Chromium(III) picolinate</b> (CrPic<sub>3</sub>) is a chemical compound sold as a nutritional supplement to treat type 2 diabetes and promote weight loss.<span class="mw-ref" id="cite_ref-1"><a href="#cite_note-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> This bright-red coordination compound is derived from <a href="Chromium.htm" tppabs="https://ptable.com/wiki/compounds/A/Chromium" title="Chromium">chromium</a>(III) and <a href="Picolinic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Picolinic_acid" title="Picolinic acid">picolinic acid</a>.  Large quantities of chromium are needed for <a href="Glucose.htm" tppabs="https://ptable.com/wiki/compounds/A/Glucose" title="Glucose">glucose</a> utilization by <a href="Insulin.htm" tppabs="https://ptable.com/wiki/compounds/A/Insulin" title="Insulin">insulin</a> in normal health, but deficiency is extremely common and has been observed in people receiving 100% of their nutrient needs intravenously, i.e., total parenteral nutrition diets.<span class="mw-ref" id="cite_ref-2"><a href="#cite_note-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Chromium has been identified as regulating insulin by increasing the sensitivity of the insulin receptor.<span class="mw-ref" id="cite_ref-3"><a href="#cite_note-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> As such, chromium(III) picolinate has been proposed as a treatment for type 2 diabetes, although its effectiveness remains controversial due to conflicting evidence from human trials.<span class="mw-ref" id="cite_ref-Cr50yr_4-0"><a href="#cite_note-Cr50yr-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<span>
</span><table class="infobox bordered" style="border-collapse:collapse; width:22em; text-align:left; ;">
<caption style="text-align:center;">Chromium(III) picolinate</caption>
<tbody><tr> 
<td colspan="2" style="text-align:center; padding:2px;"><figure-inline><img src="../I/m/Chromium_picolinate.png" tppabs="https://ptable.com/wiki/compounds/I/m/Chromium_picolinate.png" data-file-width="1295" data-file-height="1382" data-file-type="bitmap" height="213" width="200"></figure-inline></td></tr>
<tr>

<td colspan="2" class="borderless" style="text-align:center">
<table border="0" style="width:100%;">
<tbody><tr><td style="border-right:1px solid #aaa;"><center><div class="thumb tnone"></div><div class="thumbinner" style="width:112px"><img src="../I/m/Chromium(III)_picolinate_3D_ball.png" tppabs="https://ptable.com/wiki/compounds/I/m/Chromium(III)_picolinate_3D_ball.png" data-file-width="1983" data-file-height="2000" data-file-type="bitmap" height="111" width="110"><div class="thumbcaption" style="text-align: left">Ball and Stick model of chromium (III) picolinate</div></div></center></td>

<td><center><div class="thumb tnone"></div><div class="thumbinner" style="width:112px"><img src="../I/m/Chromium(III)_picolinate_3D_spacefill.png" tppabs="https://ptable.com/wiki/compounds/I/m/Chromium(III)_picolinate_3D_spacefill.png" data-file-width="1951" data-file-height="2000" data-file-type="bitmap" height="113" width="110"><div class="thumbcaption" style="text-align: left">Spacefill model of chromium (III) picolinate</div></div></center></td></tr>
</tbody></table></td></tr>

<tr>
<th colspan="2" style="background: #f8eaba; text-align: center;">Names</th></tr>

<tr>

<td colspan="2" style="text-align:left;">IUPAC name
<div style="max-width:22em; word-wrap:break-word; padding-left:1.7em;">Tris(picolinate)chromium(III)</div></td></tr>

<tr>
<th colspan="2" style="background: #f8eaba; text-align: center;">Identifiers</th></tr>

<tr>

<td><div style="padding:0.1em 0;line-height:1.2em;">CAS Number</div></td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=14639-25-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=14639-25-9'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=14639-25-9" class="external text external">14639-25-9</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr>

<tr>
<td><div style="padding:0.1em 0;line-height:1.2em;">3D model (JSmol)</div></td>
<td><div class="plainlist"><ul><li>ionic form:<span> </span><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=c1ccnc%28c1%29C%28%3DO%29%5BO-%5D.c1ccnc%28c1%29C%28%3DO%29%5BO-%5D.c1ccnc%28c1%29C%28%3DO%29%5BO-%5D.%5BCr%2B3%5D  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=c1ccnc%28c1%29C%28%3DO%29%5BO-%5D.c1ccnc%28c1%29C%28%3DO%29%5BO-%5D.c1ccnc%28c1%29C%28%3DO%29%5BO-%5D.%5BCr%2B3%5D'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=c1ccnc%28c1%29C%28%3DO%29%5BO-%5D.c1ccnc%28c1%29C%28%3DO%29%5BO-%5D.c1ccnc%28c1%29C%28%3DO%29%5BO-%5D.%5BCr%2B3%5D" class="external text external">Interactive image</a></span></li><li>coordination form:<span> </span><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=c0ccc%5Bn%2B%5D1c0C%28%3DO%29O%5BCr-3%5D123%28OC%28%3DO%29c0%5Bn%2B%5D2cccc0%29OC%28%3DO%29c0%5Bn%2B%5D3cccc0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=c0ccc%5Bn%2B%5D1c0C%28%3DO%29O%5BCr-3%5D123%28OC%28%3DO%29c0%5Bn%2B%5D2cccc0%29OC%28%3DO%29c0%5Bn%2B%5D3cccc0'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=c0ccc%5Bn%2B%5D1c0C%28%3DO%29O%5BCr-3%5D123%28OC%28%3DO%29c0%5Bn%2B%5D2cccc0%29OC%28%3DO%29c0%5Bn%2B%5D3cccc0" class="external text external">Interactive image</a></span></li></ul></div></td></tr>

<tr>



<td>ChEBI</td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=50369  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=50369'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=50369" class="external text external">CHEBI:50369</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr>

<tr>

<td>ChemSpider</td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.133913.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.133913.html'" tppabs="http://www.chemspider.com/Chemical-Structure.133913.html" class="external text external">133913</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr>

<tr>

<td><span>ECHA InfoCard</span></td>
<td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.131.423  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.131.423'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.131.423" class="external text external">100.131.423</a></td></tr>
<tr>






<td><div style="padding:0.1em 0;line-height:1.2em;">PubChem <abbr>CID</abbr></div></td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/151932  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/151932'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/151932" class="external text external">151932</a></span></li></ul></div></td></tr>

<tr>

<td>UNII</td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=S71T8B8Z6P  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=S71T8B8Z6P'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=S71T8B8Z6P" class="external text external">S71T8B8Z6P</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr>

<tr>

<td><div style="padding:0.1em 0;line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></div></td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID1024831  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID1024831'" tppabs="https://comptox.epa.gov/dashboard/DTXSID1024831" class="external text external">DTXSID1024831</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr>

<tr>
<td colspan="2"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left; text-align:left; font-weight:normal; background:transparent;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="border-top:1px solid #ccc; padding:0.2em 0 0.2em 1.5em; text-align:left;"><div style="word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;">InChI=1S/3C6H5NO2.Cr/c3*8-6(9)5-3-1-2-4-7-5;/h3*1-4H,(H,8,9);/q;;;+3/p-3<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div><div style="word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;">Key:<span>&nbsp;</span>CBDQOLKNTOMMTL-UHFFFAOYSA-K<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></div></li><li style="line-height: inherit; margin: 0"><div style="border-top:1px solid #ccc; padding:0.2em 0 0.2em 1.5em; text-align:left;"><div style="word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;">InChI=1/3C6H5NO2.Cr/c3*8-6(9)5-3-1-2-4-7-5;/h3*1-4H,(H,8,9);/q;;;+3/p-3</div><div style="word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;">Key:<span>&nbsp;</span>CBDQOLKNTOMMTL-DFZHHIFOAM</div></div></li></ul>
</div></td></tr>
<tr>
<td colspan="2"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left; text-align:left; font-weight:normal; background:transparent;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="border-top:1px solid #ccc; padding:0.2em 0 0.2em 1.6em; word-wrap:break-word; text-indent:-1.5em; text-align:left; font-size:11px; line-height:120%;">ionic form:<span> </span>c1ccnc(c1)C(=O)[O-].c1ccnc(c1)C(=O)[O-].c1ccnc(c1)C(=O)[O-].[Cr+3]</div></li><li style="line-height: inherit; margin: 0"><div style="border-top:1px solid #ccc; padding:0.2em 0 0.2em 1.6em; word-wrap:break-word; text-indent:-1.5em; text-align:left; font-size:11px; line-height:120%;">coordination form:<span> </span>c0ccc[n+]1c0C(=O)O[Cr-3]123(OC(=O)c0[n+]2cccc0)OC(=O)c0[n+]3cccc0</div></li></ul>
</div></td></tr>

<tr>
<th colspan="2" style="background: #f8eaba; text-align: center;">Properties</th></tr>

<tr>
<td><div style="padding:0.1em 0;line-height:1.2em;">Chemical formula</div></td>

<td>Cr(C<sub>6</sub>H<sub>4</sub>NO<sub>2</sub>)<sub>3</sub><span> </span></td></tr>

<tr>
<td>Molar mass</td>

<td>418.33 g/mol<span> </span> <span> </span></td></tr>

<tr>








<td colspan="2" style="text-align:left; background:#f8eaba;"><div style="margin:0 auto; text-align:left;"><div style="padding:0.1em 0;line-height:1.2em;">Except where otherwise noted, data are given for materials in their standard state (at 25<span>&nbsp;</span>°C [77<span>&nbsp;</span>°F], 100<span>&nbsp;</span>kPa).</div></div></td></tr>

<tr style="background:#f8eaba; border-top:2px solid transparent;">
<td colspan="2" style="text-align:center;"><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="12" width="12"></span></figure-inline><span style="display:none">Y</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=443523561&page2=Chromium%28III%29+picolinate  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=443523561&page2=Chromium%28III%29+picolinate'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=443523561&page2=Chromium%28III%29+picolinate" class="external text external">verify</a></span><span>&nbsp;</span>(what is<span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup><span>&nbsp;</span>?)</td></tr>

<tr style="background:#f8eaba; border-top:2px solid transparent;">
<td colspan="2" style="text-align:center;">Infobox<span>&nbsp;</span>references</td></tr>

<tr style="background:#f8eaba;">
<td style="width:40%; max-height:1px; border-top:2px solid transparent; border-right:1px solid transparent;"></td>
<td style="width:60%; max-height:1px; border-top:2px solid transparent; border-left:1px solid transparent;"></td></tr>


</tbody></table>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>A study in 1989 suggested that chromium(III) picolinate may assist in weight loss and increase muscle mass which led to an increase in the usage of chromium(III) picolinate supplements, resulting in it being for a while the second most widely used supplement behind calcium.<span class="mw-ref" id="cite_ref-Cr50yr_4-1"><a href="#cite_note-Cr50yr-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> A 2013 Cochrane review was unable to find "reliable evidence to inform firm decisions" to support such claims.<span class="mw-ref" id="cite_ref-ReferenceA_5-0"><a href="#cite_note-ReferenceA-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Research has generally shown that it improves insulin sensitivity by either prolonging its activity or up-regulating the production of mRNA to produce more insulin receptors.</p>

<p>Amongst the transition metals, Cr<sup>3+</sup> is the most controversial in terms of nutritional value and toxicity.<span class="mw-ref" id="cite_ref-Levina2008_6-0"><a href="#cite_note-Levina2008-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> This controversy centers on whether Cr<sup>3+</sup> provides any nutritional benefits.<span class="mw-ref" id="cite_ref-Levina2008_6-1"><a href="#cite_note-Levina2008-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Feng_7-0"><a href="#cite_note-Feng-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Furthermore, this controversy is amplified by the fact that no Cr-containing biomolecules have had their structure characterized, nor has the mode of action been determined. The first experiment that led to the discovery of Cr<sup>3+</sup> playing a role in glucose metabolism proposed that the biologically active form of the metal existed in a protein called <i>glucose tolerance factor</i>, however, new evidence suggests that it is simply an artifact obtained from isolation procedures.<span class="mw-ref" id="cite_ref-Cr50yr_4-2"><a href="#cite_note-Cr50yr-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Levina2008_6-2"><a href="#cite_note-Levina2008-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Cefalu2004_8-0"><a href="#cite_note-Cefalu2004-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-Anderson1998_9-0"><a href="#cite_note-Anderson1998-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> The only accepted indicator of chromium deficiency is the reversal of symptoms that occurs when chromium(III) supplementation is administered to people on total parenteral nutrition.<span class="mw-ref" id="cite_ref-Vincent2004_10-0"><a href="#cite_note-Vincent2004-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Physicochemical_properties">Physicochemical properties</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:152px"><img src="../I/m/Chromax_II.JPG" tppabs="https://ptable.com/wiki/compounds/I/m/Chromax_II.JPG" data-file-width="4912" data-file-height="3264" data-file-type="bitmap" height="100" width="150"><div class="thumbcaption" style="text-align: left">Watch glass with two grams of chromium(III) picolinate</div></div></div>
<div class="thumb tright"><div class="thumbinner" style="width:152px"><img src="../I/m/Chromium(III)_picolinate_3D_skeletal.png" tppabs="https://ptable.com/wiki/compounds/I/m/Chromium(III)_picolinate_3D_skeletal.png" data-file-width="1841" data-file-height="2000" data-file-type="bitmap" height="163" width="150"><div class="thumbcaption" style="text-align: left">Skeletal stick model (hydrogen atoms omitted) of the chromium(III) picolinate complex</div></div></div>
<p>Chromium(III) picolinate is a pinkish-red compound and was first reported in 1917.<span class="mw-ref" id="cite_ref-Cr50yr_4-3"><a href="#cite_note-Cr50yr-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Vincent2001_11-0"><a href="#cite_note-Vincent2001-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> It is poorly soluble in water, having a solubility of 600 μM in water at near neutral pH.<span class="mw-ref" id="cite_ref-Feng_7-1"><a href="#cite_note-Feng-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Similar to other chromium(III) compounds, it is relatively inert and unreactive, meaning that this complex is stable at ambient conditions and high temperatures are required to decompose the compound.<span class="mw-ref" id="cite_ref-Abou2014_12-0"><a href="#cite_note-Abou2014-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> At lower pH levels, the complex hydrolyzes to release <a href="Picolinic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Picolinic_acid" title="Picolinic acid">picolinic acid</a> and free Cr<sup>3+</sup>.<span class="mw-ref" id="cite_ref-Feng_7-2"><a href="#cite_note-Feng-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Structure">Structure</h3></summary>
    

<p>Chromium(III) picolinate has a distorted octahedral geometry and is isostructural to <a href="Cobalt.htm" tppabs="https://ptable.com/wiki/compounds/A/Cobalt" title="Cobalt">cobalt</a> (III) and <a href="Manganese.htm" tppabs="https://ptable.com/wiki/compounds/A/Manganese" title="Manganese">manganese</a> (III) counterparts.<span class="mw-ref" id="cite_ref-Costa2003_13-0"><a href="#cite_note-Costa2003-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Stearns1992_14-0"><a href="#cite_note-Stearns1992-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Chromium(III) is a hard lewis acid and as such has high affinity to the carboxylate oxygen and medium affinity to the <a href="Pyridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pyridine" title="Pyridine">pyridine</a> nitrogen of <a href="Picolinic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Picolinic_acid" title="Picolinic acid">picolinate</a>.<span class="mw-ref" id="cite_ref-Costa2003_13-1"><a href="#cite_note-Costa2003-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Hakimi_15-0"><a href="#cite_note-Hakimi-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Each picolinate ligand acts as a bidentate chelating agent and neutralizes the +3 charge of Cr<sup>3+</sup>. Evidence that the Cr<sup>3+</sup> center coordinates to the pyridine nitrogen comes from a shift in the IR spectra of a C=N vibration at 1602.4<span>&nbsp;</span>cm<sup>−1</sup> for free picolinic acid to 1565.9<span>&nbsp;</span>cm<sup>−1</sup> for chromium(III) picolinate.<span class="mw-ref" id="cite_ref-Costa2003_13-2"><a href="#cite_note-Costa2003-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> The bond length between Cr<sup>3+</sup> and the nitrogen atom of the pyridine ring on picoliante ranges from 2.047 to 2.048 Å.<span class="mw-ref" id="cite_ref-Stearns1992_14-1"><a href="#cite_note-Stearns1992-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> The picolinate ligand coordinates to Cr<sup>3+</sup> only when deprotonated and this is evident by the disappearance of IR bands ranging from 2400–2800<span>&nbsp;</span>cm<sup>−1</sup> (centered at 2500<span>&nbsp;</span>cm<sup>−1</sup>) and 1443<span>&nbsp;</span>cm<sup>−1</sup>, corresponding to the O-H stretching and bending, respectively, on the carboxyl functional group.<span class="mw-ref" id="cite_ref-Abou2014_12-1"><a href="#cite_note-Abou2014-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Costa2003_13-3"><a href="#cite_note-Costa2003-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Furthermore, this IR shift also indicates that only one oxygen atom from the carboxylate of picolinate coordinates to the Cr<sup>3+</sup> center.<span class="mw-ref" id="cite_ref-Abou2014_12-2"><a href="#cite_note-Abou2014-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Costa2003_13-4"><a href="#cite_note-Costa2003-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Hakimi_15-1"><a href="#cite_note-Hakimi-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> The Cr-O bond length ranges from 1.949 to 1.957 Å.<span class="mw-ref" id="cite_ref-Stearns1992_14-2"><a href="#cite_note-Stearns1992-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> The crystal structure has only been recently described in 2013.<span class="mw-ref" id="cite_ref-Hakimi_15-2"><a href="#cite_note-Hakimi-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Water does not coordinate to the Cr<sup>3+</sup> center and is instead thought to hydrogen bond between other Cr(Pic)<sub>3</sub> complexes to form a network of Cr(Pic)<sub>3</sub> complexes.<span class="mw-ref" id="cite_ref-Hakimi_15-3"><a href="#cite_note-Hakimi-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Biochemistry_of_chromium(III)_picolinate">Biochemistry of chromium(III) picolinate</h2></summary>
    


<p>Chromium has been identified as an essential nutrient in maintaining normal blood glucose levels and as such, it is proposed to interact with two naturally occurring molecules found within the body.<span class="mw-ref" id="cite_ref-Cefalu2004_8-1"><a href="#cite_note-Cefalu2004-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> These interactions are most likely to occur through coordination with hard ligands such as aspartate and glutamate, as Cr(III) itself is a hard metal.</p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Absorption_and_excretion_of_chromium(III)_picolinate">Absorption and excretion of chromium(III) picolinate</h3></summary>
    
<p>Once chromium(III) picolinate is ingested and enters the stomach, acidic hydrolysis of the complex occurs when in contact with the stomach mucosa.<span class="mw-ref" id="cite_ref-Lukaski_16-0"><a href="#cite_note-Lukaski-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> The hydrolyzed Cr<sup>3+</sup> is present in the hexaaqua form and polymerizes to form an insoluble Cr(III)-hydroxide-oxide (the process of olation) once it reaches the alkaline pH of the small intestine.<span class="mw-ref" id="cite_ref-Laschinsky_17-0"><a href="#cite_note-Laschinsky-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> Approximately 2% of Cr<sup>3+</sup> is absorbed through the gut as chromium(III) picolinate via unsaturated passive transport.<span class="mw-ref" id="cite_ref-Vincent2001_11-1"><a href="#cite_note-Vincent2001-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Although absorption is low, CrPic<sub>3</sub> absorbs more efficiently than other organic and inorganic sources (i.e. CrCl<sub>3</sub> and chromium nicotinate) and thus accumulate at higher concentrations in tissues.<span class="mw-ref" id="cite_ref-Anderson1998_9-1"><a href="#cite_note-Anderson1998-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-Debski_18-0"><a href="#cite_note-Debski-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> This has been one major selling point for chromium(III) picolinate over other chromium(III) supplements. Organic sources tend to absorb better as they have ligands which are more lipophilic and usually neutralize the charge of the metal, thus permitting for easier passage through the intestinal membrane.<span class="mw-ref" id="cite_ref-Debski_18-1"><a href="#cite_note-Debski-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>It has also been shown that dietary factors affect Cr<sup>3+</sup> absorption. Starch, simple sugars, <a href="Oxalic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxalic_acid" title="Oxalic acid">oxalic acid</a>, and some amino acids tend to increase the rate of absorption of chromium(III). This is a result of ligand chelation, converting hexaaqua Cr<sup>3+</sup> into more lipophilic forms.<span class="mw-ref" id="cite_ref-Debski_18-2"><a href="#cite_note-Debski-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> In contrast, calcium, magnesium, titanium, zinc, vanadium, and iron reduce the rate of absorption.<span class="mw-ref" id="cite_ref-Debski_18-3"><a href="#cite_note-Debski-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> Presumably, these ions introduce new metal-ligand equilibria, thus decreasing the lipophilic ligand pool available to Cr<sup>3+</sup>. Once absorbed into the bloodstream, 80% of the Cr<sup>3+</sup> from CrPic<sub>3</sub> is passed along to transferrin.<span class="mw-ref" id="cite_ref-Lukaski_16-1"><a href="#cite_note-Lukaski-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-Debski_18-4"><a href="#cite_note-Debski-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-Vincent2015_19-0"><a href="#cite_note-Vincent2015-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> The exact mechanism of release is currently unknown, however, it is believed not to occur by a single electron reduction, as in the case of Fe<sup>3+</sup>, due to the high instability of Cr<sup>2+</sup>.<span class="mw-ref" id="cite_ref-Laschinsky_17-1"><a href="#cite_note-Laschinsky-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> Administered Cr<sup>3+</sup> can be found in all tissues ranging from 10–100 μg/kg body weight.<span class="mw-ref" id="cite_ref-Debski_18-5"><a href="#cite_note-Debski-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> It is excreted primarily in the urine (80%) while the rest is excreted in sweat and feces.<span class="mw-ref" id="cite_ref-Debski_18-6"><a href="#cite_note-Debski-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Binding_of_chromium(III)_to_transferrin">Binding of chromium(III) to transferrin</h4></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:152px"><img src="../I/m/Transferrin_binding_sites.png" tppabs="https://ptable.com/wiki/compounds/I/m/Transferrin_binding_sites.png" data-file-width="545" data-file-height="737" data-file-type="bitmap" height="203" width="150"><div class="thumbcaption" style="text-align: left">The 2 binding sites of transferrin. When iron saturation is high, Cr<sup>3+</sup> can compete with Fe<sup>3+</sup> for binding to the C-lobe.<span class="mw-ref" id="cite_ref-Quarles_20-0"><a href="#cite_note-Quarles-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></div></div></div>
<p>Transferrin, in addition to chromodulin has been identified as a major physiological chromium transport agent,<span class="mw-ref" id="cite_ref-Vincent2015_19-1"><a href="#cite_note-Vincent2015-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-Vincent2012_21-0"><a href="#cite_note-Vincent2012-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> although a recent study found that Cr<sup>3+</sup> in fact disables transferrin from acting as a metal ion transport agent.<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> While transferrin is highly specific for ferric ions, at normal conditions, only 30% of transferrin molecules are saturated with ferric ions, allowing for other metals, particularly those with a large charge to size ratio, to bind as well.<span class="mw-ref" id="cite_ref-Feng_7-3"><a href="#cite_note-Feng-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-Vincent2001_11-2"><a href="#cite_note-Vincent2001-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-Quarles_20-1"><a href="#cite_note-Quarles-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> The binding sites consist of a C-lobe and an N-lobe which are nearly identical in structure.<span class="mw-ref" id="cite_ref-Quarles_20-2"><a href="#cite_note-Quarles-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> Each lobe contains <a href="Aspartic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Aspartic_acid" title="Aspartic acid">aspartic acid</a>, <a href="Histidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histidine" title="Histidine">histidine</a>, 2 <a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine">tyrosine</a> residues and a bicarbonate ion that acts as a bidentate ligand to allow iron or other metals to bind to transferrin in a distorted octahedral geometry.<span class="mw-ref" id="cite_ref-Vincent2015_19-2"><a href="#cite_note-Vincent2015-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-Quarles_20-3"><a href="#cite_note-Quarles-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-Vincent2012_21-1"><a href="#cite_note-Vincent2012-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span>  Evidence supporting the binding of Cr<sup>3+</sup> to transferrin comes from extensive clinical studies that showed a positive correlation between levels of ferritin and of fasting <a href="Glucose.htm" tppabs="https://ptable.com/wiki/compounds/A/Glucose" title="Glucose">glucose</a>, <a href="Insulin.htm" tppabs="https://ptable.com/wiki/compounds/A/Insulin" title="Insulin">insulin</a>, and glycosylated hemoglobin (Hb1Ac) levels.<span class="mw-ref" id="cite_ref-Feng_7-4"><a href="#cite_note-Feng-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Furthermore, an in vivo study in rats showed that 80% of isotopically labelled Cr<sup>3+</sup> ended up on transferrin while the rest were bound to albumin. An in vitro study showed that when chromium(III) chloride was added to isolated transferrin, the Cr<sup>3+</sup> readily bound transferrin, owing to changes in the UV-Vis spectrum.<span class="mw-ref" id="cite_ref-Vincent2001_11-3"><a href="#cite_note-Vincent2001-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-Vincent2015_19-3"><a href="#cite_note-Vincent2015-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-VincentWiley_23-0"><a href="#cite_note-VincentWiley-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> The formation constant for Cr<sup>3+</sup> in the C-lobe is 1.41 x 10<sup>10</sup> M<sup>−1</sup> and 2.04 x 10<sup>5</sup> M<sup>−1</sup> in the N-lobe, which indicates that Cr<sup>3+</sup> preferentially binds the C-lobe.<span class="mw-ref" id="cite_ref-Feng_7-5"><a href="#cite_note-Feng-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-Vincent2015_19-4"><a href="#cite_note-Vincent2015-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-Quarles_20-4"><a href="#cite_note-Quarles-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> Overall, the formation constant for chromium(III) is lower than that of the ferric ion.<span class="mw-ref" id="cite_ref-Vincent2015_19-5"><a href="#cite_note-Vincent2015-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> The bicarbonate ligand is crucial in binding Cr<sup>3+</sup> as when bicarbonate concentrations are very low, the binding affinity is also significantly lower.<span class="mw-ref" id="cite_ref-Vincent2015_19-6"><a href="#cite_note-Vincent2015-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> Electron paramagnetic resonance (EPR) studies have shown that below pH 6, chromium(III) binds only to the N-lobe and that at near neutral pH, chromium(III) binds to the C-lobe as well.<span class="mw-ref" id="cite_ref-Feng_7-6"><a href="#cite_note-Feng-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Chromium(III) can compete with the ferric ion for binding to the C-lobe when the saturation greatly exceeds 30%.<span class="mw-ref" id="cite_ref-Quarles_20-5"><a href="#cite_note-Quarles-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> As such, these effects are only seen in patients suffering from hemochromatosis, an iron-storage disease characterized by excessive iron saturation in transferrin.<span class="mw-ref" id="cite_ref-VincentWiley_23-1"><a href="#cite_note-VincentWiley-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Regulation_of_glycogen_metabolism_insulin.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Regulation_of_glycogen_metabolism_insulin.svg.png" data-file-width="1020" data-file-height="735" data-file-type="drawing" height="159" width="220"><div class="thumbcaption" style="text-align: left">This diagram shows the insulin pathway and its role in regulating blood glucose levels</div></div></div>

<p>Low-molecular-weight chromium-binding substance (LMWCr; also known as chromodulin) is an oligopeptide that seems to bind chromium(III) in the body.<span class="mw-ref" id="cite_ref-pmid18769887_24-0"><a href="#cite_note-pmid18769887-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> It consists of four amino acid residues; aspartate, <a href="Cysteine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cysteine" title="Cysteine">cysteine</a>, glutamate, and <a href="Glycine.htm" tppabs="https://ptable.com/wiki/compounds/A/Glycine" title="Glycine">glycine</a>, bonded with four (Cr<sup>3+</sup>) centers.<span class="mw-ref" id="cite_ref-Feng_7-7"><a href="#cite_note-Feng-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-Vincent2004_10-1"><a href="#cite_note-Vincent2004-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Vincent2000_25-0"><a href="#cite_note-Vincent2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> It interacts with the insulin receptor, by prolonging kinase activity through stimulating the tyrosine kinase pathway, thus leading to improved glucose absorption.<span class="mw-ref" id="cite_ref-Vincent2015_19-7"><a href="#cite_note-Vincent2015-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-pmid11472024_26-0"><a href="#cite_note-pmid11472024-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> It has been confused with glucose tolerance factor. Despite recent efforts to characterize chromodulin, the exact structure is still relatively unknown.<span class="mw-ref" id="cite_ref-pmid8283288_27-0"><a href="#cite_note-pmid8283288-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>

<p>Although chromodulin's exact mechanism of action on the insulin receptor is currently unknown, one commonly described mechanism is presented below. This proposed mechanism has the highest amount of agreement with various experiments involving chromodulin.<span class="mw-ref" id="cite_ref-Levina2008_6-3"><a href="#cite_note-Levina2008-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Vincent2001_11-4"><a href="#cite_note-Vincent2001-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-Laschinsky_17-2"><a href="#cite_note-Laschinsky-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-VincentWiley_23-2"><a href="#cite_note-VincentWiley-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>

<p>Normally, chromodulin exists in the apochromodulin form, which is free of Cr(III) ions and has minimal activity on insulin receptors.<span class="mw-ref" id="cite_ref-VincentWiley_23-3"><a href="#cite_note-VincentWiley-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> The apochromodulin is stored in insulin sensitive cells in the nucleus. When blood glucose levels rise, <a href="Insulin.htm" tppabs="https://ptable.com/wiki/compounds/A/Insulin" title="Insulin">insulin</a> is released into the bloodstream and binds to an external α-subunit of the insulin receptor, a transmembrane protein.<span class="mw-ref" id="cite_ref-Vincent2000_25-1"><a href="#cite_note-Vincent2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> The insulin receptor consists of 2 extracellular α-subunits and 2 transmembrane β-subunits.<span class="mw-ref" id="cite_ref-VincentWiley_23-4"><a href="#cite_note-VincentWiley-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> As soon as insulin binds to the insulin receptor, a conformational change in the receptor occurs, causing all 3 <a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine">tyrosine</a> residues (located in the β-subunits) to be phosphorylated. This activates the receptor and allows it to transmit the signal from insulin to the cell.<span class="mw-ref" id="cite_ref-Vincent2004_10-2"><a href="#cite_note-Vincent2004-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-VincentWiley_23-5"><a href="#cite_note-VincentWiley-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-Vincent2000_25-2"><a href="#cite_note-Vincent2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span>
As mentioned above, absorbed chromium(III) picolinate eventually gives up Cr<sup>3+</sup> to transferrin. In turn, transferrin transports Cr<sup>3+</sup> to insulin sensitive cells (i.e. adipocytes) where it binds to apochromodulin to form holochromodulin.<span class="mw-ref" id="cite_ref-VincentWiley_23-6"><a href="#cite_note-VincentWiley-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> Holochromodulin binds to the insulin receptor, which assists in maintaining the active conformation of the insulin receptor by prolonging the kinase activity of kinases or up-regulating the amount of insulin receptor mRNA levels, thus decreasing blood glucose levels.<span class="mw-ref" id="cite_ref-Vincent2004_10-3"><a href="#cite_note-Vincent2004-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>Experiments were able to show that chromium(III) was capable of up-regulating insulin-stimulated insulin signal transduction via affecting downstream molecules of the IR, as evidenced by enhanced levels of tyrosine phosphorylation of IRS-1, elevated <a href="Threonine.htm" tppabs="https://ptable.com/wiki/compounds/A/Threonine" title="Threonine">Thr308</a> and <a href="Serine.htm" tppabs="https://ptable.com/wiki/compounds/A/Serine" title="Serine">Ser473</a> phosphorylation of Akt, and increased PI3-K activity in a variety of cellular and animal models.<span class="mw-ref" id="cite_ref-Kitamura2008_28-0"><a href="#cite_note-Kitamura2008-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> The increased IRS-1 phosphorylation led to increased insulin receptor sensitivity while Akt and PI3-K led to enhanced GLUT4 translocation to the cell surface, thus causing greater uptake of glucose.<span class="mw-ref" id="cite_ref-Kitamura2008_28-1"><a href="#cite_note-Kitamura2008-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></p>

<p>It has also been shown that chromium(III) can alleviate insulin resistance by reducing endoplasmic reticulum (ER) stress.<span class="mw-ref" id="cite_ref-Kitamura2008_28-2"><a href="#cite_note-Kitamura2008-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> ER stress is defined as an accumulation of misfolded and unfolded proteins in the ER lumen.<span class="mw-ref" id="cite_ref-Kitamura2008_28-3"><a href="#cite_note-Kitamura2008-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> ER stress leads to stimulation of c-Jun terminal kinase (JNK), which in turn phosphorylates the serine residue of IRS, leading to suppression of insulin signaling cascade and less glucose uptake.<span class="mw-ref" id="cite_ref-Hua2012_29-0"><a href="#cite_note-Hua2012-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> Experimental findings suggest that chromium inhibits ER stress and hence the suppression of insulin signaling is uplifted.<span class="mw-ref" id="cite_ref-Hua2012_29-1"><a href="#cite_note-Hua2012-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> The exact mechanism is unknown.<span class="mw-ref" id="cite_ref-Hua2012_29-2"><a href="#cite_note-Hua2012-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>

<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Oxidation_of_a_Cys_residue_to_sulfenic_acid_by_chromium_species.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Oxidation_of_a_Cys_residue_to_sulfenic_acid_by_chromium_species.jpg" data-file-width="996" data-file-height="193" data-file-type="bitmap" height="43" width="220"><div class="thumbcaption" style="text-align: left">Oxidation of a Cys residue to sulfenic acid.</div></div></div>
<p>Another way that Cr(III) may prolong the insulin receptor's kinase activity is through the oxidation of a critical active site cysteine residue on protein-tyrosine phosphatase 1B (PTP1B). Normally, PTP1B dephosphorylates phosphotyrosine residues by carrying out nucleophilic attack on the phosphate group via its cysteine residue, thus inactivating the insulin receptor.<span class="mw-ref" id="cite_ref-Tonks_30-0"><a href="#cite_note-Tonks-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> This process removes the phosphate group from the tyrosine residue to form a Cys—S—PO<sub>3</sub><sup>2−</sup> group that is subsequently hydrolyzed by water to regenerate the cysteine residue, permitting for another round of action.<span class="mw-ref" id="cite_ref-Tonks_30-1"><a href="#cite_note-Tonks-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span>  Research has shown that chromium(III) may in fact cause irreversible inhibition of PTP1B. It is thought that Cr(III) is converted to Cr(VI) or Cr(V) (through the action of oxidoreductases) which then oxidize the thiol of the cysteine residue on PTP1B to sulfenic acid, consequently rendering it unable to attack the phosphate group on phosphotyrosine.<span class="mw-ref" id="cite_ref-metaldiabeticdrugs_31-0"><a href="#cite_note-metaldiabeticdrugs-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> However, this is only a plausible mechanism, and no direct evidence has been shown to support this hypothesis.<span class="mw-ref" id="cite_ref-Tonks_30-2"><a href="#cite_note-Tonks-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span>
When the signal cascade is turned off, holochromodulin is eliminated in urine since the formation constant is too large to remove Cr(III) directly.<span class="mw-ref" id="cite_ref-Feng_7-8"><a href="#cite_note-Feng-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Experimental evidence has shown that the loss of chromodulin from cells is correlated with an increase in chromium concentrations in the urine after ingesting food rich in carbohydrates (i.e. glucose).<span class="mw-ref" id="cite_ref-Vincent2000_25-3"><a href="#cite_note-Vincent2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Health_claims_and_debates">Health claims and debates</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Body_weight">Body weight</h3></summary>
    
<p>Chromium(III) picolinate has been marketed in the United States as an aid to body development for athletes and as a means of losing weight. Reviews have reported either no effect on either muscle growth or fat loss,<span class="mw-ref" id="cite_ref-JBVincent_32-0"><a href="#cite_note-JBVincent-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> or else a modest but statistically significant -1.1<span>&nbsp;</span>kg (2.4<span>&nbsp;</span>lb) weight loss in trials longer than 12 weeks.<span class="mw-ref" id="cite_ref-ReferenceA_5-1"><a href="#cite_note-ReferenceA-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> The European Food Safety Authority reviewed the literature and concluded that there was insufficient evidence to support a claim.<span class="mw-ref" id="cite_ref-EFSA2010_33-0"><a href="#cite_note-EFSA2010-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Diabetes">Diabetes</h3></summary>
    
<p>There are claims that the picolinate form of chromium supplementation aids in reducing insulin resistance and improving glucose metabolism, particularly in type 2 diabetics, but reviews showed no association between chromium and glucose or insulin concentrations for non-diabetics, and inconclusive results for diabetics.<span class="mw-ref" id="cite_ref-MDAlthuius_34-0"><a href="#cite_note-MDAlthuius-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span><span class="mw-ref" id="cite_ref-Balk2007_35-0"><a href="#cite_note-Balk2007-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> The authors of the second review mentioned that chromium picolinate decreased HbA1c levels by 0.7% in type 2 diabetes patients, they observed that poor quality studies produced larger positive outcomes than higher quality studies.<span class="mw-ref" id="cite_ref-Balk2007_35-1"><a href="#cite_note-Balk2007-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><span class="mw-ref" id="cite_ref-Suksomboon2014_36-0"><a href="#cite_note-Suksomboon2014-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span> Two reviews concluded that chromium(III) picolinate may be more effective at lowering blood glucose levels compared to other chromium-containing dietary supplements.<span class="mw-ref" id="cite_ref-Balk2007_35-2"><a href="#cite_note-Balk2007-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><span class="mw-ref" id="cite_ref-37"><a href="#cite_note-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span></p>

<p>In 2005, the U.S. Food and Drug Administration (FDA) approved a qualified health claim for chromium picolinate as a dietary supplement relating to insulin resistance and risk of type 2 diabetes. Any company wishing to make such a claim must use the exact wording: "One small study suggests that chromium picolinate may reduce the risk of insulin resistance, and therefore possibly may reduce the risk of type 2 diabetes. FDA concludes, however, that the existence of such a relationship between chromium picolinate and either insulin resistance or type 2 diabetes is highly uncertain." As part of the petition review process, the FDA rejected other claims for reducing abnormally elevated blood sugar, risk of cardiovascular disease, risk of retinopathy or risk of kidney disease.<span class="mw-ref" id="cite_ref-38"><a href="#cite_note-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> In 2006 the FDA added that the "relationship between chromium(III) picolinate intake and insulin resistance is highly uncertain".<span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Variability_of_studies">Variability of studies</h3></summary>
    
<p>There was no consistency observed in clinical results relating chromium(III) picolinate to adequate treatment of type 2 diabetes. This is due to the degree of glucose intolerance of patients that participate in the clinical studies.<span class="mw-ref" id="cite_ref-Anderson1998_9-2"><a href="#cite_note-Anderson1998-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> Glucose intolerance is a gradient and the intensity is affected by ethnicity, degree of obesity, age, distribution of body fat and many other factors.<span class="mw-ref" id="cite_ref-Anderson1998_9-3"><a href="#cite_note-Anderson1998-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> In some studies, low dosages of the supplement were given, however, a suitable amount of chromium(III) picolinate must be administrated to a person before any appreciable drop in glucose levels are observed due to differing levels of insulin resistance. Another important point to mention is that diabetes is not always caused by glucose intolerance.<span class="mw-ref" id="cite_ref-Anderson1998_9-4"><a href="#cite_note-Anderson1998-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> As mentioned before, Cr(III) has been shown to only influence glucose intolerance and not insulin levels. Furthermore, the environments in which the studies were performed were not consistent. The levels of stress, diets consumed by patients and patient genetics were variable among study subjects.<span class="mw-ref" id="cite_ref-Anderson1998_9-5"><a href="#cite_note-Anderson1998-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> This is also true of the controls amongst different studies in which the subjects having diabetes were already being treated with a wide variety of antidiabetic drugs, which can reduce the effects of chromium on affecting insulin activity.<span class="mw-ref" id="cite_ref-Hua2012_29-3"><a href="#cite_note-Hua2012-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> This could explain why animal studies tend to yield more positive results owing to the fact that these diabetic animals were not treated with antidiabetic drugs for the control group.<span class="mw-ref" id="cite_ref-Hua2012_29-4"><a href="#cite_note-Hua2012-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> Also, as mentioned in the absorption and excretion section, the absorption/bioavailability of chromium(III) picolinate is influenced by the diet. Collectively, these different factors have contributed to the variability in the studies.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Safety_and_toxicity">Safety and toxicity</h2></summary>
    
<p>Initial concerns were raised that chromium(III) picolinate is more likely to cause DNA damage and mutation than other forms of trivalent chromium,<span class="mw-ref" id="cite_ref-SChaudhary_40-0"><a href="#cite_note-SChaudhary-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span> but these results are also debated.<span class="mw-ref" id="cite_ref-pmid_17512455_41-0"><a href="#cite_note-pmid_17512455-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> These concerns were based, in part, on studies in fruit flies, where chromium(III) picolinate supplementation generates chromosomal aberrations, impedes progeny development,<span class="mw-ref" id="cite_ref-pmid_16887379_42-0"><a href="#cite_note-pmid_16887379-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> and causes sterility and lethal mutations.<span class="mw-ref" id="cite_ref-pmid_12649323_43-0"><a href="#cite_note-pmid_12649323-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span></p>

<p>A study was published to assess the toxicity of Cr(III) picolinate on humans.<span class="mw-ref" id="cite_ref-Kato_44-0"><a href="#cite_note-Kato-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> The researchers that conducted this study used previous knowledge that Cr(III) is reduced to Cr(II) by cellular reductants such as <a href="Nicotinamide_adenine_dinucleotide.htm" tppabs="https://ptable.com/wiki/compounds/A/NADH" title="NADH" class="mw-redirect">NADH</a> or <a href="Cysteine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cysteine" title="Cysteine">cysteine</a>.<span class="mw-ref" id="cite_ref-Kato_44-1"><a href="#cite_note-Kato-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> This reduced form of Cr(II) is shown to react with H<sub>2</sub>O<sub>2</sub> to generate radical species which in turn oxidize DNA base pairs.<span class="mw-ref" id="cite_ref-Tsou_45-0"><a href="#cite_note-Tsou-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span><span class="mw-ref" id="cite_ref-Ozawa_46-0"><a href="#cite_note-Ozawa-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> With this knowledge in mind, the researchers administered ten women with 400 μg of chromium(III) picolinate a day for an eight-week period.<span class="mw-ref" id="cite_ref-Kato_44-2"><a href="#cite_note-Kato-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> By measuring the amount of an oxidized DNA base pair, 5-hydroxymethyl uracil using antibody titers, the group could infer the amount of DNA base pair oxidation occurring in direct relation to chromium(III) picolinate.<span class="mw-ref" id="cite_ref-Kato_44-3"><a href="#cite_note-Kato-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> The results of the study suggested that chromium(III) picolinate itself does not cause significant chromosomal damage in vivo.<span class="mw-ref" id="cite_ref-Kato_44-4"><a href="#cite_note-Kato-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span></p>

<p>Generally speaking, it has been shown that chromium(III) picolinate is not toxic to humans. For most adults, it can be taken orally in doses up 1000<span>&nbsp;</span>μg per day.<span class="mw-ref" id="cite_ref-Jeejeebhoy_47-0"><a href="#cite_note-Jeejeebhoy-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> This low toxicity has general been associated with low absorbance of Cr(III) in the body through the lungs, skin and gastrointestinal tract,<span class="mw-ref" id="cite_ref-Fairhurst_48-0"><a href="#cite_note-Fairhurst-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> coupled with high excretion. Normally, 99% of chromium(III) taken can be recovered in the feces of the user. There have been isolated incidences of chromium(III) supplementation leading to kidney failure, however this relationship is unclear and has yet to be tested.<span class="mw-ref" id="cite_ref-Wasser_49-0"><a href="#cite_note-Wasser-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Regulation_of_chromium(III)_picolinate">Regulation of chromium(III) picolinate</h2></summary>
    
<p>In 2004, the UK Food Standards Agency advised consumers to use other forms of trivalent chromium in preference to chromium(III) picolinate until specialist advice was received from the Committee on Mutagenicity. This was due to concerns raised by the Expert Group on Vitamins and Minerals that chromium(III) picolinate might be genotoxic (cause cancer). The committee also noted two case reports of kidney failure that might have been caused by this supplement and called for further research into its safety.<span class="mw-ref" id="cite_ref-50"><a href="#cite_note-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span><span class="mw-ref" id="cite_ref-51"><a href="#cite_note-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span> In December 2004, the Committee on Mutagenicity published its findings, which concluded that "overall it can be concluded that the balance of the data suggest that chromium(III) picolinate should be regarded as not being mutagenic in vitro" and that "the available in-vivo tests in mammals with chromium(III) picolinate are negative".<span class="mw-ref" id="cite_ref-52"><a href="#cite_note-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> Following these findings, the UK Food Standards Agency withdrew its advice to avoid chromium(III) picolinate, though it plans to keep its advice about chromium supplements under review.<span class="mw-ref" id="cite_ref-53"><a href="#cite_note-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span></p>

<p>In 2010, chromium(III) picolinate was approved by Health Canada to be used in dietary supplements. Approved labeling statements include: a factor in the maintenance of good health, provides support for healthy glucose metabolism, helps the body to metabolize carbohydrates and helps the body to metabolize fats.<span class="mw-ref" id="cite_ref-54"><a href="#cite_note-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-1"> <span id="mw-reference-text-cite_note-1" class="mw-reference-text"><cite id="CITEREFPreussEchardPerriconeBagchi2008" class="citation journal cs1">Preuss, H. G.; Echard, B.; Perricone, N. V.; Bagchi, D.; Yasmin, T.; Stohs, S. J. (2008). "Comparing metabolic effects of six different commercial trivalent chromium compounds". <i>Journal of Inorganic Biochemistry</i>. <b>102</b> (11): 1986–1990. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jinorgbio.2008.07.012  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jinorgbio.2008.07.012'" tppabs="https://doi.org/10.1016%2Fj.jinorgbio.2008.07.012" class="external text external">10.1016/j.jinorgbio.2008.07.012</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18774175  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18774175'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18774175" class="external text external">18774175</a>.</cite></span></li><li id="cite_note-2"> <span id="mw-reference-text-cite_note-2" class="mw-reference-text"><a href="javascript:if(confirm('http://www.food.gov.uk/multimedia/pdfs/reviewofchrome.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.food.gov.uk/multimedia/pdfs/reviewofchrome.pdf'" tppabs="http://www.food.gov.uk/multimedia/pdfs/reviewofchrome.pdf" class="external text external">Review of Chromium</a> <a href="javascript:if(confirm('https://web.archive.org/web/20120207123911/http://www.food.gov.uk/multimedia/pdfs/reviewofchrome.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120207123911/http://www.food.gov.uk/multimedia/pdfs/reviewofchrome.pdf'" tppabs="https://web.archive.org/web/20120207123911/http://www.food.gov.uk/multimedia/pdfs/reviewofchrome.pdf" class="external text external">Archived</a><span> February 7, 2012, at the </span>Wayback Machine Expert Group on Vitamins and Minerals Review of Chromium, 12 August 2002</span></li><li id="cite_note-3"> <span id="mw-reference-text-cite_note-3" class="mw-reference-text"><cite id="CITEREFStearns_DM2000" class="citation journal cs1">Stearns DM (2000). "Is chromium a trace essential metal?". <i>BioFactors</i>. <b>11</b> (3): 149–62. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fbiof.5520110301  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fbiof.5520110301'" tppabs="https://doi.org/10.1002%2Fbiof.5520110301" class="external text external">10.1002/biof.5520110301</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10875302  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10875302'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10875302" class="external text external">10875302</a>.</cite></span></li><li id="cite_note-Cr50yr-4"> <span id="mw-reference-text-cite_note-Cr50yr-4" class="mw-reference-text"><cite id="CITEREFVincent2010" class="citation journal cs1">Vincent, John (2010). "Chromium: celebrating 50 years as an essential element?". <i>Dalton Transactions</i>. <b>39</b> (16): 3787–3794. doi:<a href="javascript:if(confirm('https://doi.org/10.1039%2FB920480F  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1039%2FB920480F'" tppabs="https://doi.org/10.1039%2FB920480F" class="external text external">10.1039/B920480F</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20372701  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20372701'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20372701" class="external text external">20372701</a>.</cite></span></li><li id="cite_note-ReferenceA-5"> <span id="mw-reference-text-cite_note-ReferenceA-5" class="mw-reference-text"><cite id="CITEREFTianGuoWangHe2013" class="citation journal cs1">Tian, H; Guo, X; Wang, X; He, Z; Sun, R; Ge, S; Zhang, Z (2013). "Chromium picolinate supplementation for overweight or obese adults". <i>The Cochrane Database of Systematic Reviews</i>. <b>11</b> (11): CD010063. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD010063.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD010063.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD010063.pub2" class="external text external">10.1002/14651858.CD010063.pub2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24293292  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24293292'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24293292" class="external text external">24293292</a>. CD010063.</cite></span></li><li id="cite_note-Levina2008-6"> <span id="mw-reference-text-cite_note-Levina2008-6" class="mw-reference-text"><cite id="CITEREFLevinaLay2008" class="citation journal cs1">Levina, Aviva; Lay, Peter (2008). "Chemical Properties and Toxcity of Chromium (III) Nutritional Supplements". <i>Chemical Research in Toxicology</i>. <b>21</b> (3): 563–571. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Ftx700385t  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Ftx700385t'" tppabs="https://doi.org/10.1021%2Ftx700385t" class="external text external">10.1021/tx700385t</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18237145  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18237145'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18237145" class="external text external">18237145</a>.</cite></span></li><li id="cite_note-Feng-7"> <span id="mw-reference-text-cite_note-Feng-7" class="mw-reference-text"><cite id="CITEREFFeng2007" class="citation book cs1">Feng, Weiyue (2007). <a href="javascript:if(confirm('http://survival-training.info/Library/Chemistry/Chemistry%20-%20The%20Nutritional%20Biochemistry%20of%20Chromium-III%20-%20J.%20Vincent.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://survival-training.info/Library/Chemistry/Chemistry%20-%20The%20Nutritional%20Biochemistry%20of%20Chromium-III%20-%20J.%20Vincent.pdf'" tppabs="http://survival-training.info/Library/Chemistry/Chemistry%20-%20The%20Nutritional%20Biochemistry%20of%20Chromium-III%20-%20J.%20Vincent.pdf" class="external text external">"Chapter 6—The Transport of chromium (III) in the body: Implications for Function"</a> <span class="cs1-format">(PDF)</span>.  In Vincent, John (ed.). <i>The Nutritional Biochemistry of Chromium (III)</i>. Amsterdam: Elsevier B.V. pp.<span>&nbsp;</span>121–137. ISBN<span>&nbsp;</span><bdi>978-0-444-53071-4</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2015</span>.</cite></span></li><li id="cite_note-Cefalu2004-8"> <span id="mw-reference-text-cite_note-Cefalu2004-8" class="mw-reference-text"><cite id="CITEREFCefaluHu2004" class="citation journal cs1">Cefalu, William; Hu, Frank (2004). <a href="javascript:if(confirm('http://care.diabetesjournals.org/content/27/11/2741.full  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://care.diabetesjournals.org/content/27/11/2741.full'" tppabs="http://care.diabetesjournals.org/content/27/11/2741.full" class="external text external">"Role of Chromium in Human Health and in Diabetes"</a>. <i>Diabetes Care</i>. <b>27</b> (11): 2741–2751. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.2337%2Fdiacare.27.11.2741  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2337%2Fdiacare.27.11.2741'" tppabs="https://doi.org/10.2337%2Fdiacare.27.11.2741" class="external text external">10.2337/diacare.27.11.2741</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15505017  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15505017'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15505017" class="external text external">15505017</a><span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2015</span>.</cite></span></li><li id="cite_note-Anderson1998-9"> <span id="mw-reference-text-cite_note-Anderson1998-9" class="mw-reference-text"><cite id="CITEREFAnderson1998" class="citation journal cs1">Anderson, Richard (1998). "Chromium, Glucose Intolerance and Diabetes". <i>Journal of the American College of Nutrition</i>. <b>17</b> (6): 548–555. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F07315724.1998.10718802  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F07315724.1998.10718802'" tppabs="https://doi.org/10.1080%2F07315724.1998.10718802" class="external text external">10.1080/07315724.1998.10718802</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9853533  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9853533'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9853533" class="external text external">9853533</a>.</cite></span></li><li id="cite_note-Vincent2004-10"> <span id="mw-reference-text-cite_note-Vincent2004-10" class="mw-reference-text"><cite id="CITEREFVincent2004" class="citation journal cs1">Vincent, John (2004). <a href="javascript:if(confirm('https://doi.org/10.1079/PNS2003315  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1079/PNS2003315'" tppabs="https://doi.org/10.1079/PNS2003315" class="external text external">"Recent advances in the nutritional biochemistry of trivalent chromium"</a>. <i>Proceedings of the Nutrition Society</i>. <b>63</b> (1): 41–47. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1079%2FPNS2003315  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1079%2FPNS2003315'" tppabs="https://doi.org/10.1079%2FPNS2003315" class="external text external">10.1079/PNS2003315</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15070438  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15070438'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15070438" class="external text external">15070438</a>.</cite></span></li><li id="cite_note-Vincent2001-11"> <span id="mw-reference-text-cite_note-Vincent2001-11" class="mw-reference-text"><cite id="CITEREFVincent2001" class="citation journal cs1">Vincent, John (2001). "The Bioinorganic Chemistry of Chromium (III)". <i>Polyhedron</i>. <b>20</b> (1–2): 1–26. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0277-5387%2800%2900624-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0277-5387%2800%2900624-0'" tppabs="https://doi.org/10.1016%2FS0277-5387%2800%2900624-0" class="external text external">10.1016/S0277-5387(00)00624-0</a>.</cite></span></li><li id="cite_note-Abou2014-12"> <span id="mw-reference-text-cite_note-Abou2014-12" class="mw-reference-text"><cite id="CITEREFAbou–GamraAbdel–Messih2014" class="citation journal cs1">Abou–Gamra, Zeinab; Abdel–Messih, Michel (2014). "Correlation of thermal and spectral properties of chromium(III) picolinate complex and kinetic study of its thermal degradation". <i>Journal of Thermal Analysis and Calorimetry</i>. <b>117</b> (2): 993–1000. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs10973-014-3768-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs10973-014-3768-5'" tppabs="https://doi.org/10.1007%2Fs10973-014-3768-5" class="external text external">10.1007/s10973-014-3768-5</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:93050541  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:93050541'" tppabs="https://api.semanticscholar.org/CorpusID:93050541" class="external text external">93050541</a>.</cite></span></li><li id="cite_note-Costa2003-13"> <span id="mw-reference-text-cite_note-Costa2003-13" class="mw-reference-text"><cite id="CITEREFParajón–CostaWagnerBaran2003" class="citation journal cs1">Parajón–Costa, Beatriz; Wagner, Claudia; Baran, Enrique (2003). "Voltammetric and Spectroscopic Study of Chromium(III)/Picolinate Complexes". <i>Zeitschrift für Anorganische und Allgemeine Chemie</i>. <b>629</b> (6): 1085–1090. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fzaac.200300050  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fzaac.200300050'" tppabs="https://doi.org/10.1002%2Fzaac.200300050" class="external text external">10.1002/zaac.200300050</a>.</cite></span></li><li id="cite_note-Stearns1992-14"> <span id="mw-reference-text-cite_note-Stearns1992-14" class="mw-reference-text"><cite id="CITEREFStearnsArmstrong1992" class="citation journal cs1">Stearns, Diane; Armstrong, William (1992). "Mononuclear and binuclear chromium(III) picolinate complexes". <i>Inorganic Chemistry</i>. <b>31</b> (25): 5178–5184. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fic00051a007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fic00051a007'" tppabs="https://doi.org/10.1021%2Fic00051a007" class="external text external">10.1021/ic00051a007</a>.</cite></span></li><li id="cite_note-Hakimi-15"> <span id="mw-reference-text-cite_note-Hakimi-15" class="mw-reference-text"><cite id="CITEREFHakimi2013" class="citation journal cs1">Hakimi, Mohammad (2013). <a href="javascript:if(confirm('http://kpubs.org/article/articleMain.kpubs?articleANo=JCGMDC_2013_v57n6_721  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://kpubs.org/article/articleMain.kpubs?articleANo=JCGMDC_2013_v57n6_721'" tppabs="http://kpubs.org/article/articleMain.kpubs?articleANo=JCGMDC_2013_v57n6_721" class="external text external">"Structural and Spectral Characterization of a Chromium (III) Picolinate Complex: Introducing a New Redox Reaction"</a>. <i>Journal of the Korean Chemical Society</i>. <b>57</b> (6): 721–725. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.5012%2Fjkcs.2013.57.6.721  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5012%2Fjkcs.2013.57.6.721'" tppabs="https://doi.org/10.5012%2Fjkcs.2013.57.6.721" class="external text external">10.5012/jkcs.2013.57.6.721</a></span><span class="reference-accessdate">. Retrieved <span class="nowrap">1 April</span> 2015</span>.</cite></span></li><li id="cite_note-Lukaski-16"> <span id="mw-reference-text-cite_note-Lukaski-16" class="mw-reference-text"><cite id="CITEREFLukaski2007" class="citation book cs1">Lukaski, Henry (2007). <a href="javascript:if(confirm('http://survival-training.info/Library/Chemistry/Chemistry%20-%20The%20Nutritional%20Biochemistry%20of%20Chromium-III%20-%20J.%20Vincent.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://survival-training.info/Library/Chemistry/Chemistry%20-%20The%20Nutritional%20Biochemistry%20of%20Chromium-III%20-%20J.%20Vincent.pdf'" tppabs="http://survival-training.info/Library/Chemistry/Chemistry%20-%20The%20Nutritional%20Biochemistry%20of%20Chromium-III%20-%20J.%20Vincent.pdf" class="external text external">"Chapter 4—Effects of Chromium(III) as a nutritional supplement"</a> <span class="cs1-format">(PDF)</span>.  In Vincent, John (ed.). <i>The Nutritional Biochemistry of Chromium (III)</i>. Amsterdam: Elsevier B.V. pp.<span>&nbsp;</span>57–70. ISBN<span>&nbsp;</span><bdi>978-0-444-53071-4</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2015</span>.</cite></span></li><li id="cite_note-Laschinsky-17"> <span id="mw-reference-text-cite_note-Laschinsky-17" class="mw-reference-text"><cite id="CITEREFLaschinskyKottwitzFreundDresow2012" class="citation journal cs1">Laschinsky, Niels; Kottwitz, Karin; Freund, Barbara; Dresow, bernd; Fischer, Roland; Nielsen, Peter (2012). "Bioavailability of chromium(III)-supplements in rats and humans". <i>BioMetals</i>. <b>25</b> (5): 1051–1060. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs10534-012-9571-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs10534-012-9571-5'" tppabs="https://doi.org/10.1007%2Fs10534-012-9571-5" class="external text external">10.1007/s10534-012-9571-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22814636  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22814636'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22814636" class="external text external">22814636</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:1533593  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:1533593'" tppabs="https://api.semanticscholar.org/CorpusID:1533593" class="external text external">1533593</a>.</cite></span></li><li id="cite_note-Debski-18"> <span id="mw-reference-text-cite_note-Debski-18" class="mw-reference-text"><cite id="CITEREFDebskiGoniewiczKrzyzowskalLewicka2014" class="citation journal cs1">Debski, B.; Goniewicz, M.; Krzyzowskal, M.; Lewicka, A.; Lewickil, S.; Niemcewiz, M.; Zdanowskil, R. (2014). <a href="javascript:if(confirm('https://doi.org/10.5604/1232-1966.1108599  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5604/1232-1966.1108599'" tppabs="https://doi.org/10.5604/1232-1966.1108599" class="external text external">"The role of Chromium III in the organism and its possible use in diabetes and obesity treatment"</a>. <i>Annals of Agricultural and Environmental Medicine</i>. <b>21</b> (2): 331–335. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.5604%2F1232-1966.1108599  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5604%2F1232-1966.1108599'" tppabs="https://doi.org/10.5604%2F1232-1966.1108599" class="external text external">10.5604/1232-1966.1108599</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24959784  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24959784'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24959784" class="external text external">24959784</a>.</cite></span></li><li id="cite_note-Vincent2015-19"> <span id="mw-reference-text-cite_note-Vincent2015-19" class="mw-reference-text"><cite id="CITEREFVincent2015" class="citation journal cs1">Vincent, John (2015). "Is the Pharmacological Mode of Action of Chromium (III) as a secondary messenger?". <i>Biological Trace Element Research</i>. <b>166</b> (1): 7–12. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs12011-015-0231-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs12011-015-0231-9'" tppabs="https://doi.org/10.1007%2Fs12011-015-0231-9" class="external text external">10.1007/s12011-015-0231-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25595680  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25595680'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25595680" class="external text external">25595680</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:16895342  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:16895342'" tppabs="https://api.semanticscholar.org/CorpusID:16895342" class="external text external">16895342</a>.</cite></span></li><li id="cite_note-Quarles-20"> <span id="mw-reference-text-cite_note-Quarles-20" class="mw-reference-text"><cite id="CITEREFQuarlesMarcusBrumaghim2011" class="citation journal cs1">Quarles, C.; Marcus, R.; Brumaghim, Julia (2011). "Competitive binding of Fe<sup>3+</sup>, Cr<sup>3+</sup>, and Ni<sup>2+</sup> to transferrin". <i>Journal of Biological Inorganic Chemistry</i>. <b>16</b> (6): 913–921. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00775-011-0792-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00775-011-0792-9'" tppabs="https://doi.org/10.1007%2Fs00775-011-0792-9" class="external text external">10.1007/s00775-011-0792-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21678080  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21678080'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21678080" class="external text external">21678080</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:24302252  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:24302252'" tppabs="https://api.semanticscholar.org/CorpusID:24302252" class="external text external">24302252</a>.</cite></span></li><li id="cite_note-Vincent2012-21"> <span id="mw-reference-text-cite_note-Vincent2012-21" class="mw-reference-text"><cite id="CITEREFVincent2012" class="citation journal cs1">Vincent, John (2012). "The binding and transport of alternative metals by transferrin". <i>Biochimica et Biophysica Acta (BBA) - General Subjects</i>. <b>1820</b> (3): 362–378. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.bbagen.2011.07.003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.bbagen.2011.07.003'" tppabs="https://doi.org/10.1016%2Fj.bbagen.2011.07.003" class="external text external">10.1016/j.bbagen.2011.07.003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21782896  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21782896'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21782896" class="external text external">21782896</a>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite id="CITEREFLevinaPhamLay2016" class="citation journal cs1">Levina, Aviva; Pham, T. H. Nguyen; Lay, Peter A. (2016-05-01). <a href="javascript:if(confirm('https://doi.org/10.1002/anie.201602996  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002/anie.201602996'" tppabs="https://doi.org/10.1002/anie.201602996" class="external text external">"Binding of Chromium(III) to Transferrin Could be Involved in Detoxification of Dietary Chromium(III) Rather Than Transport of an Essential Trace Element"</a>. <i>Angewandte Chemie International Edition</i>. <b>55</b> (28): 8104–8107. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1002%2Fanie.201602996  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fanie.201602996'" tppabs="https://doi.org/10.1002%2Fanie.201602996" class="external text external">10.1002/anie.201602996</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1521-3773  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1521-3773'" tppabs="https://www.worldcat.org/issn/1521-3773" class="external text external">1521-3773</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27197571  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27197571'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27197571" class="external text external">27197571</a>.</cite></span></li><li id="cite_note-VincentWiley-23"> <span id="mw-reference-text-cite_note-VincentWiley-23" class="mw-reference-text"><cite class="citation book cs1">Vincent, John (2012). "Biochemical Mechanisms".  In Vincent, John (ed.). <i>The Bioinorganic Chemistry of Chromium</i>. Chichester, UK: John Wiley &amp; Sons. pp.<span>&nbsp;</span>125–167. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F9781118458891.ch6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F9781118458891.ch6'" tppabs="https://doi.org/10.1002%2F9781118458891.ch6" class="external text external">10.1002/9781118458891.ch6</a>. ISBN<span>&nbsp;</span><bdi>9780470664827</bdi>.</cite></span></li><li id="cite_note-pmid18769887-24"> <span id="mw-reference-text-cite_note-pmid18769887-24" class="mw-reference-text"><cite id="CITEREFVieraDavis-McGibony2008" class="citation journal cs1">Viera M, Davis-McGibony CM (2008). "Isolation and characterization of low-molecular-weight chromium-binding substance (LMWCr) from chicken liver". <i>Protein J</i>. <b>27</b> (6): 371–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs10930-008-9146-z  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs10930-008-9146-z'" tppabs="https://doi.org/10.1007%2Fs10930-008-9146-z" class="external text external">10.1007/s10930-008-9146-z</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18769887  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18769887'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18769887" class="external text external">18769887</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:32564084  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:32564084'" tppabs="https://api.semanticscholar.org/CorpusID:32564084" class="external text external">32564084</a>.</cite></span></li><li id="cite_note-Vincent2000-25"> <span id="mw-reference-text-cite_note-Vincent2000-25" class="mw-reference-text"><cite id="CITEREFVincent2000" class="citation journal cs1">Vincent, John (2000). <a href="javascript:if(confirm('https://doi.org/10.1093/jn/130.4.715  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jn/130.4.715'" tppabs="https://doi.org/10.1093/jn/130.4.715" class="external text external">"The Biochemistry of Chromium"</a>. <i>The Journal of Nutrition</i>. <b>130</b> (4): 715–718. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjn%2F130.4.715  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjn%2F130.4.715'" tppabs="https://doi.org/10.1093%2Fjn%2F130.4.715" class="external text external">10.1093/jn/130.4.715</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10736319  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10736319'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10736319" class="external text external">10736319</a>.</cite></span></li><li id="cite_note-pmid11472024-26"> <span id="mw-reference-text-cite_note-pmid11472024-26" class="mw-reference-text"><cite id="CITEREFClodfelderEmamaulleeHepburnChakov2001" class="citation journal cs1">Clodfelder BJ, Emamaullee J, Hepburn DD, Chakov NE, Nettles HS, Vincent JB (2001). "The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin". <i>J. Biol. Inorg. Chem</i>. <b>6</b> (5–6): 608–17. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs007750100238  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs007750100238'" tppabs="https://doi.org/10.1007%2Fs007750100238" class="external text external">10.1007/s007750100238</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11472024  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11472024'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11472024" class="external text external">11472024</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:8956685  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:8956685'" tppabs="https://api.semanticscholar.org/CorpusID:8956685" class="external text external">8956685</a>.</cite></span></li><li id="cite_note-pmid8283288-27"> <span id="mw-reference-text-cite_note-pmid8283288-27" class="mw-reference-text"><cite id="CITEREFVincent1994" class="citation journal cs1">Vincent JB (1994). <a href="javascript:if(confirm('http://jn.nutrition.org/content/124/1/117.full.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://jn.nutrition.org/content/124/1/117.full.pdf'" tppabs="http://jn.nutrition.org/content/124/1/117.full.pdf" class="external text external">"Relationship between glucose tolerance factor and low-molecular-weight chromium-binding substance"</a> <span class="cs1-format">(PDF)</span>. <i>J. Nutr</i>. <b>124</b> (1): 117–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Fjn%2F124.1.117  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjn%2F124.1.117'" tppabs="https://doi.org/10.1093%2Fjn%2F124.1.117" class="external text external">10.1093/jn/124.1.117</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8283288  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8283288'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8283288" class="external text external">8283288</a>.</cite></span></li><li id="cite_note-Kitamura2008-28"> <span id="mw-reference-text-cite_note-Kitamura2008-28" class="mw-reference-text"><cite id="CITEREFKitamura2008" class="citation journal cs1">Kitamura, Masanori (2008). "Endoplasmic reticulum stress and unfolded protein response in renal pathophysiology: Janus faces". <i>American Journal of Physiology</i>. <b>295</b> (2): 323–334. doi:<a href="javascript:if(confirm('https://doi.org/10.1152%2Fajprenal.00050.2008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1152%2Fajprenal.00050.2008'" tppabs="https://doi.org/10.1152%2Fajprenal.00050.2008" class="external text external">10.1152/ajprenal.00050.2008</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18367660  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18367660'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18367660" class="external text external">18367660</a>.</cite></span></li><li id="cite_note-Hua2012-29"> <span id="mw-reference-text-cite_note-Hua2012-29" class="mw-reference-text"><cite id="CITEREFHuaClarkRenSreejayan2012" class="citation journal cs1">Hua, Yinan; Clark, Suzanne; Ren, Jun; Sreejayan, Nair (2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308119  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308119'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308119" class="external text external">"Molecular Mechanisms of Chromium in Alleviating Insulin Resistance"</a>. <i>Journal of Nutritional Biochemistry</i>. <b>23</b> (4): 313–319. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jnutbio.2011.11.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jnutbio.2011.11.001'" tppabs="https://doi.org/10.1016%2Fj.jnutbio.2011.11.001" class="external text external">10.1016/j.jnutbio.2011.11.001</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308119  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308119'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308119" class="external text external">3308119</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22423897  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22423897'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22423897" class="external text external">22423897</a>.</cite></span></li><li id="cite_note-Tonks-30"> <span id="mw-reference-text-cite_note-Tonks-30" class="mw-reference-text"><cite id="CITEREFTonks2003" class="citation journal cs1">Tonks, Nicholas (2003). "PTP1B: From the sidelines to the front lines!". <i>FEBS Letters</i>. <b>546</b> (1): 140–148. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0014-5793%2803%2900603-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0014-5793%2803%2900603-3'" tppabs="https://doi.org/10.1016%2FS0014-5793%2803%2900603-3" class="external text external">10.1016/S0014-5793(03)00603-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12829250  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12829250'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12829250" class="external text external">12829250</a>.</cite></span></li><li id="cite_note-metaldiabeticdrugs-31"> <span id="mw-reference-text-cite_note-metaldiabeticdrugs-31" class="mw-reference-text"><cite id="CITEREFLevina2011" class="citation journal cs1">Levina, Aviva (2011). "Metal based anti-diabetic drugs: advances and challenges". <i>Dalton Transactions</i>. <b>40</b> (44): 11675–1686. doi:<a href="javascript:if(confirm('https://doi.org/10.1039%2FC1DT10380F  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1039%2FC1DT10380F'" tppabs="https://doi.org/10.1039%2FC1DT10380F" class="external text external">10.1039/C1DT10380F</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21750828  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21750828'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21750828" class="external text external">21750828</a>.</cite></span></li><li id="cite_note-JBVincent-32"> <span id="mw-reference-text-cite_note-JBVincent-32" class="mw-reference-text"><cite id="CITEREFVincent_J.B.SackRoffmanFinch2003" class="citation journal cs1">Vincent J.B.; Sack, DA; Roffman, M; Finch, M; Komorowski, JR (2003). "The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent". <i>Sports Medicine</i>. <b>33</b> (3): 213–230. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00007256-200333030-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00007256-200333030-00004'" tppabs="https://doi.org/10.2165%2F00007256-200333030-00004" class="external text external">10.2165/00007256-200333030-00004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12656641  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12656641'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12656641" class="external text external">12656641</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:9981172  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:9981172'" tppabs="https://api.semanticscholar.org/CorpusID:9981172" class="external text external">9981172</a>.</cite></span></li><li id="cite_note-EFSA2010-33"> <span id="mw-reference-text-cite_note-EFSA2010-33" class="mw-reference-text"><cite class="citation journal cs1"><a href="javascript:if(confirm('https://doi.org/10.2903/j.efsa.2010.1732  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2903/j.efsa.2010.1732'" tppabs="https://doi.org/10.2903/j.efsa.2010.1732" class="external text external">"Scientific Opinion on the substantiation of health claims related to chromium and contribution to normal macronutrient metabolism (ID 260, 401, 4665, 4666, 4667), maintenance of normal blood glucose concentrations (ID 262, 4667), contribution to the maintenance or achievement of a normal body weight (ID 339, 4665, 4666), and reduction of tiredness and fatigue (ID 261) pursuant to Article 13(1) of Regulation (EC) No 1924/2006"</a>. <i>EFSA Journal</i>. <b>8</b> (10). 2010. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.2903%2Fj.efsa.2010.1732  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2903%2Fj.efsa.2010.1732'" tppabs="https://doi.org/10.2903%2Fj.efsa.2010.1732" class="external text external">10.2903/j.efsa.2010.1732</a></span>.</cite></span></li><li id="cite_note-MDAlthuius-34"> <span id="mw-reference-text-cite_note-MDAlthuius-34" class="mw-reference-text"><cite id="CITEREFAlthuisJordanLudingtonWittes2002" class="citation journal cs1">Althuis MD, Jordan NE, Ludington EA, Wittes JT (1 July 2002). <a href="javascript:if(confirm('https://doi.org/10.1093/ajcn/76.1.148  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/ajcn/76.1.148'" tppabs="https://doi.org/10.1093/ajcn/76.1.148" class="external text external">"Glucose and insulin responses to dietary chromium supplements: a meta-analysis"</a>. <i>American Journal of Clinical Nutrition</i>. <b>76</b> (1): 148–155. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fajcn%2F76.1.148  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fajcn%2F76.1.148'" tppabs="https://doi.org/10.1093%2Fajcn%2F76.1.148" class="external text external">10.1093/ajcn/76.1.148</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12081828  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12081828'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12081828" class="external text external">12081828</a>.</cite></span></li><li id="cite_note-Balk2007-35"> <span id="mw-reference-text-cite_note-Balk2007-35" class="mw-reference-text"><cite id="CITEREFBalk_EM,_Tatsioni_A,_Lichtenstein_AH,_Lau_J,_Pittas_AG2007" class="citation journal cs1">Balk EM, Tatsioni A, Lichtenstein AH, Lau J, Pittas AG (2007). <a href="javascript:if(confirm('http://care.diabetesjournals.org/cgi/pmidlookup?view=long&pmid=17519436  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://care.diabetesjournals.org/cgi/pmidlookup?view=long&pmid=17519436'" tppabs="http://care.diabetesjournals.org/cgi/pmidlookup?view=long&pmid=17519436" class="external text external">"Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials"</a>. <i>Diabetes Care</i>. <b>30</b> (8): 2154–2163. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.2337%2Fdc06-0996  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2337%2Fdc06-0996'" tppabs="https://doi.org/10.2337%2Fdc06-0996" class="external text external">10.2337/dc06-0996</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17519436  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17519436'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17519436" class="external text external">17519436</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-Suksomboon2014-36"> <span id="mw-reference-text-cite_note-Suksomboon2014-36" class="mw-reference-text"><cite id="CITEREFSuksomboonPoolsupYuwanakom2014" class="citation journal cs1">Suksomboon, N.; Poolsup, N.; Yuwanakom, A. (2014). "Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes". <i>Journal of Clinical Pharmacy and Therapeutics</i>. <b>39</b> (3): 292–306. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fjcpt.12147  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fjcpt.12147'" tppabs="https://doi.org/10.1111%2Fjcpt.12147" class="external text external">10.1111/jcpt.12147</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24635480  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24635480'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24635480" class="external text external">24635480</a>.</cite></span></li><li id="cite_note-37"> <span id="mw-reference-text-cite_note-37" class="mw-reference-text"><cite id="CITEREFBroadhurstDomenico2006" class="citation journal cs1">Broadhurst CL, Domenico P (December 2006). "Clinical studies on chromium picolinate supplementation in diabetes mellitus--a review". <i>Diabetes Technol. Ther</i>. <b>8</b> (6): 677–87. doi:<a href="javascript:if(confirm('https://doi.org/10.1089%2Fdia.2006.8.677  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1089%2Fdia.2006.8.677'" tppabs="https://doi.org/10.1089%2Fdia.2006.8.677" class="external text external">10.1089/dia.2006.8.677</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17109600  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17109600'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17109600" class="external text external">17109600</a>.</cite></span></li><li id="cite_note-38"> <span id="mw-reference-text-cite_note-38" class="mw-reference-text"><a href="javascript:if(confirm('https://wayback.archive-it.org/7993/20171114183739/https://www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm073017.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://wayback.archive-it.org/7993/20171114183739/https://www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm073017.htm'" tppabs="https://wayback.archive-it.org/7993/20171114183739/https://www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm073017.htm" class="external text external">Qualified Health Claims: Letter of Enforcement Discretion - Chromium Picolinate and Insulin Resistance(Docket No. 2004Q-0144)</a> (2005) U.S. Food and Drug Administration.</span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite id="CITEREFTrumboEllwood2006" class="citation journal cs1">Trumbo PR, Ellwood KC (August 2006). <a href="javascript:if(confirm('https://zenodo.org/record/1230786  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://zenodo.org/record/1230786'" tppabs="https://zenodo.org/record/1230786" class="external text external">"Chromium picolinate intake and risk of type 2 diabetes: an evidence-based review by the United States Food and Drug Administration"</a>. <i>Nutr. Rev</i>. <b>64</b> (8): 357–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1753-4887.2006.tb00220.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1753-4887.2006.tb00220.x'" tppabs="https://doi.org/10.1111%2Fj.1753-4887.2006.tb00220.x" class="external text external">10.1111/j.1753-4887.2006.tb00220.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16958312  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16958312'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16958312" class="external text external">16958312</a>.</cite></span></li><li id="cite_note-SChaudhary-40"> <span id="mw-reference-text-cite_note-SChaudhary-40" class="mw-reference-text"><cite id="CITEREFChaudharyPinkstonRabileVan_Horn2005" class="citation journal cs1">Chaudhary S, Pinkston J, Rabile MM, Van Horn JD (2005). "Unusual reactivity in a commercial chromium supplement compared to baseline DNA cleavage with synthetic chromium complexes". <i>Journal of Inorganic Biochemistry</i>. <b>99</b> (3): 787–794. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jinorgbio.2004.12.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jinorgbio.2004.12.009'" tppabs="https://doi.org/10.1016%2Fj.jinorgbio.2004.12.009" class="external text external">10.1016/j.jinorgbio.2004.12.009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15708800  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15708800'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15708800" class="external text external">15708800</a>.</cite></span></li><li id="cite_note-pmid_17512455-41"> <span id="mw-reference-text-cite_note-pmid_17512455-41" class="mw-reference-text"><cite id="CITEREFHiningerBenarabaOsmanFaure2007" class="citation journal cs1">Hininger I, Benaraba R, Osman M, Faure H, Marie Roussel A, Anderson RA (2007). <a href="javascript:if(confirm('https://naldc-legacy.nal.usda.gov/naldc/download.xhtml?id=14276&content=PDF  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://naldc-legacy.nal.usda.gov/naldc/download.xhtml?id=14276&content=PDF'" tppabs="https://naldc-legacy.nal.usda.gov/naldc/download.xhtml?id=14276&content=PDF" class="external text external">"Safety of trivalent chromium complexes: no evidence for DNA damage in human HaCaT keratinocytes"</a>. <i>Free Radic. Biol. Med</i>. <b>42</b> (12): 1759–65. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.freeradbiomed.2007.02.034  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.freeradbiomed.2007.02.034'" tppabs="https://doi.org/10.1016%2Fj.freeradbiomed.2007.02.034" class="external text external">10.1016/j.freeradbiomed.2007.02.034</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17512455  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17512455'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17512455" class="external text external">17512455</a>.</cite></span></li><li id="cite_note-pmid_16887379-42"> <span id="mw-reference-text-cite_note-pmid_16887379-42" class="mw-reference-text"><cite id="CITEREFStallingsHepburnHannahVincent2006" class="citation journal cs1">Stallings DM, Hepburn DD, Hannah M, Vincent JB, O'Donnell J (2006). "Nutritional supplement chromium picolinate generates chromosomal aberrations and impedes progeny development in Drosophila melanogaster". <i>Mutat. Res</i>. <b>610</b> (1–2): 101–13. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.mrgentox.2006.06.019  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.mrgentox.2006.06.019'" tppabs="https://doi.org/10.1016%2Fj.mrgentox.2006.06.019" class="external text external">10.1016/j.mrgentox.2006.06.019</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16887379  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16887379'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16887379" class="external text external">16887379</a>.</cite></span></li><li id="cite_note-pmid_12649323-43"> <span id="mw-reference-text-cite_note-pmid_12649323-43" class="mw-reference-text"><cite id="CITEREFHepburnXiaoBindomVincent2003" class="citation journal cs1">Hepburn DD, Xiao J, Bindom S, Vincent JB, O'Donnell J (2003). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC152996  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC152996'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC152996" class="external text external">"Nutritional supplement chromium picolinate causes sterility and lethal mutations in Drosophila melanogaster"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>100</b> (7): 3766–71. doi:<a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.0636646100  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.0636646100'" tppabs="https://doi.org/10.1073%2Fpnas.0636646100" class="external text external">10.1073/pnas.0636646100</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC152996  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC152996'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC152996" class="external text external">152996</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12649323  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12649323'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12649323" class="external text external">12649323</a>.</cite></span></li><li id="cite_note-Kato-44"> <span id="mw-reference-text-cite_note-Kato-44" class="mw-reference-text"><cite id="CITEREFKatoVogelmanDilmanKarkoszka1998" class="citation journal cs1">Kato, Ikuko; Vogelman, Joseph; Dilman, Vladimir; Karkoszka, Jerzy; Frenkel, Krystyna; Durr, Nancy; Orentreich, Norman; Toniolo, Paolo (1998). "Effect of supplementation with chromium picolinate on antibody titers to 5—hydroxymethyl uracil". <i>European Journal of Epidemiology</i>. <b>14</b> (6): 621–626. doi:<a href="javascript:if(confirm('https://doi.org/10.1023%2FA%3A1007442203258  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1023%2FA%3A1007442203258'" tppabs="https://doi.org/10.1023%2FA%3A1007442203258" class="external text external">10.1023/A:1007442203258</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9794131  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9794131'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9794131" class="external text external">9794131</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:19071972  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:19071972'" tppabs="https://api.semanticscholar.org/CorpusID:19071972" class="external text external">19071972</a>.</cite></span></li><li id="cite_note-Tsou-45"> <span id="mw-reference-text-cite_note-Tsou-45" class="mw-reference-text"><cite id="CITEREFTsouChenLiuYang1996" class="citation journal cs1">Tsou, Tsui—Chun; Chen, Chiu—lan; Liu, Tsung—Yun; Yang, Jia-Ling (1996). <a href="javascript:if(confirm('http://carcin.oxfordjournals.org/content/17/1/103.full.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://carcin.oxfordjournals.org/content/17/1/103.full.pdf'" tppabs="http://carcin.oxfordjournals.org/content/17/1/103.full.pdf" class="external text external">"Induction of 8-hydroxydeoxyguanosine in DNA by chromium(III) plus hydrogen peroxide and its prevention by scavengers"</a> <span class="cs1-format">(PDF)</span>. <i>Carcinogenesis</i>. <b>17</b> (1): 103–108. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Fcarcin%2F17.1.103  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fcarcin%2F17.1.103'" tppabs="https://doi.org/10.1093%2Fcarcin%2F17.1.103" class="external text external">10.1093/carcin/17.1.103</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8565117  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8565117'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8565117" class="external text external">8565117</a><span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2015</span>.</cite></span></li><li id="cite_note-Ozawa-46"> <span id="mw-reference-text-cite_note-Ozawa-46" class="mw-reference-text"><cite id="CITEREFOzawaHanaki1990" class="citation journal cs1">Ozawa, T.; Hanaki, A. (1990). "Spin-trapping studies on the reactions of Cr(III) with hydrogen peroxide in the presence of biological reductants: is Cr(III) non-toxic?". <i>Biochemistry International</i>. <b>22</b> (2): 343–352. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1965278  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1965278'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1965278" class="external text external">1965278</a>.</cite></span></li><li id="cite_note-Jeejeebhoy-47"> <span id="mw-reference-text-cite_note-Jeejeebhoy-47" class="mw-reference-text"><cite id="CITEREFJeejeebhoy2009" class="citation journal cs1">Jeejeebhoy, Khursheed (2009). "The Role of Chromium in Nutrition and Therapeutics and As a Potential Toxin". <i>Nutrition Reviews</i>. <b>57</b> (11): 329–335. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1753-4887.1999.tb06909.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1753-4887.1999.tb06909.x'" tppabs="https://doi.org/10.1111%2Fj.1753-4887.1999.tb06909.x" class="external text external">10.1111/j.1753-4887.1999.tb06909.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10628183  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10628183'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10628183" class="external text external">10628183</a>.</cite></span></li><li id="cite_note-Fairhurst-48"> <span id="mw-reference-text-cite_note-Fairhurst-48" class="mw-reference-text"><cite id="CITEREFFairhurstMinty1989" class="citation book cs1">Fairhurst, S.; Minty, C. (1989). <i>The toxicity of chromium and inorganic chromium compounds</i>. Toxicity Review; 21. London: H.M.S.O. pp.<span>&nbsp;</span>1–243. ISBN<span>&nbsp;</span><bdi>9780118855211</bdi>.</cite></span></li><li id="cite_note-Wasser-49"> <span id="mw-reference-text-cite_note-Wasser-49" class="mw-reference-text"><cite id="CITEREFWasserFeldmanD'Agati1997" class="citation journal cs1">Wasser, Walter; Feldman, Nathaniel; D'Agati, Vivette (1997). "Chronic Renal Failure after Ingestion of Over-the-Counter Chromium Picolinate". <i>Annals of Internal Medicine</i>. <b>126</b> (5): 410. doi:<a href="javascript:if(confirm('https://doi.org/10.7326%2F0003-4819-126-5-199703010-00019  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.7326%2F0003-4819-126-5-199703010-00019'" tppabs="https://doi.org/10.7326%2F0003-4819-126-5-199703010-00019" class="external text external">10.7326/0003-4819-126-5-199703010-00019</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9054292  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9054292'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9054292" class="external text external">9054292</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:27418296  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:27418296'" tppabs="https://api.semanticscholar.org/CorpusID:27418296" class="external text external">27418296</a>.</cite></span></li><li id="cite_note-50"> <span id="mw-reference-text-cite_note-50" class="mw-reference-text"><a href="javascript:if(confirm('http://www.foodstandards.gov.uk/multimedia/pdfs/vitmin2003.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.foodstandards.gov.uk/multimedia/pdfs/vitmin2003.pdf'" tppabs="http://www.foodstandards.gov.uk/multimedia/pdfs/vitmin2003.pdf" class="external text external">Safe Upper Levels for Vitamins and Minerals</a> <a href="javascript:if(confirm('https://web.archive.org/web/20080704010728/http://www.foodstandards.gov.uk/multimedia/pdfs/vitmin2003.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080704010728/http://www.foodstandards.gov.uk/multimedia/pdfs/vitmin2003.pdf'" tppabs="https://web.archive.org/web/20080704010728/http://www.foodstandards.gov.uk/multimedia/pdfs/vitmin2003.pdf" class="external text external">Archived</a><span> 2008-07-04 at the </span>Wayback Machine Food Standards Agency - May 2003</span></li><li id="cite_note-51"> <span id="mw-reference-text-cite_note-51" class="mw-reference-text"><a href="javascript:if(confirm('http://www.food.gov.uk/multimedia/pdfs/evm_chromium.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.food.gov.uk/multimedia/pdfs/evm_chromium.pdf'" tppabs="http://www.food.gov.uk/multimedia/pdfs/evm_chromium.pdf" class="external text external">Risk assessment: Chromium</a> Expert Group on Vitamins and Minerals, 2003</span></li><li id="cite_note-52"> <span id="mw-reference-text-cite_note-52" class="mw-reference-text"><a href="javascript:if(confirm('http://www.advisorybodies.doh.gov.uk/Com/chromium.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.advisorybodies.doh.gov.uk/Com/chromium.htm'" tppabs="http://www.advisorybodies.doh.gov.uk/Com/chromium.htm" class="external text external">STATEMENT ON THE MUTAGENICITY OF TRIVALENT CHROMIUM AND CHROMIUM PICOLINATE</a> <a href="javascript:if(confirm('https://web.archive.org/web/20080516030629/http://www.advisorybodies.doh.gov.uk/Com/chromium.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080516030629/http://www.advisorybodies.doh.gov.uk/Com/chromium.htm'" tppabs="https://web.archive.org/web/20080516030629/http://www.advisorybodies.doh.gov.uk/Com/chromium.htm" class="external text external">Archived</a><span> 2008-05-16 at the </span>Wayback Machine COM/04/S3 - December 2004</span></li><li id="cite_note-53"> <span id="mw-reference-text-cite_note-53" class="mw-reference-text"><a href="javascript:if(confirm('http://www.food.gov.uk/news/newsarchive/2004/dec/chromiumupdate  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.food.gov.uk/news/newsarchive/2004/dec/chromiumupdate'" tppabs="http://www.food.gov.uk/news/newsarchive/2004/dec/chromiumupdate" class="external text external">Agency revises chromium picolinate advice</a> Food Standards Agency - 13 December 2004</span></li><li id="cite_note-54"> <span id="mw-reference-text-cite_note-54" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://webprod.hc-sc.gc.ca/nhpid-bdipsn/monoReq.do?id=65  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://webprod.hc-sc.gc.ca/nhpid-bdipsn/monoReq.do?id=65'" tppabs="http://webprod.hc-sc.gc.ca/nhpid-bdipsn/monoReq.do?id=65" class="external text external">"Monograph: Chromium (from Chromium picolinate)"</a>. Health Canada. December 9, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">March 24,</span> 2015</span>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><figure-inline class="noviewer"><img src="../I/m/Commons-logo.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Commons-logo.svg.png" data-file-width="1024" data-file-height="1376" data-file-type="drawing" height="16" width="12"></figure-inline><span> Media related to </span><a href="javascript:if(confirm('https://commons.wikimedia.org/wiki/Category:Chromium(III)%20picolinate  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://commons.wikimedia.org/wiki/Category:Chromium(III)%20picolinate'" tppabs="https://commons.wikimedia.org/wiki/Category:Chromium(III)%20picolinate" title="commons:Category:Chromium(III) picolinate" class="external"><span style=" ">Chromium(III) picolinate</span></a><span> at Wikimedia Commons</span></li>
<li><a href="javascript:if(confirm('http://www.merck.com/mrkshared/mmanual/section1/chapter4/4f.jsp  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.merck.com/mrkshared/mmanual/section1/chapter4/4f.jsp'" tppabs="http://www.merck.com/mrkshared/mmanual/section1/chapter4/4f.jsp" class="external text external">Merck Manual</a></li></ul>

<meta property="mw:PageProp/categorydefaultsort" content="Chromium(Iii) Picolinate">



<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-07-01" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Chromium(III)_picolinate&oldid=965530682  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Chromium(III)_picolinate&oldid=965530682'" tppabs="https://en.wikipedia.org/wiki/?title=Chromium(III)_picolinate&oldid=965530682">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>